CMIC appoints Bruce Lynn as Entrepreneur in Residence

CMIC aims to resolve key medical challenges by performing world-leading research into medical imaging, image analysis problems and applications. They have pioneered new imaging techniques and tools for image-guided interventions. 

Since its creation in 2018, the Royal Society Entrepreneur in Residence scheme has funded 65 placements in 38 UK universities. Alongside their host institution, the award holders will develop projects that build the entrepreneurial skills of staff and students, as well as their understanding of the scientific challenges being tackled in the innovation sector.

In February 2021, 16 new Entrepreneur in Residence places were awarded, including Bruce Lynn’s appointment to UCL QNIAC. Bruce is a medical imaging executive with over 30 years of technology commercialisation experience. He is an executive advisor for Queen Square Analytics and was previously CEO of UCL spinout, SmartTarget Ltd.

Bruce’s Entrepreneur in Residence project will be shaping the commercial focus for QNIAC, in partnership with Professor Daniel Alexander and Professor Geoff Parker. A key focus for the centre is creating an environment in which SMEs, including spin-out companies, can thrive and take new technologies into clinical use at the most rapid pace possible. 

“The Entrepreneur in Residence award will enable me to build on my experience working with other UCL spin-outs - Motilent, SmartTarget, Queen Square Analytics – to develop an even deeper understanding about what facilitation most helps and which obstacles are the most difficult in the process of technology translation.  

“Furthermore, I look forward to applying the understanding to assist budding initiatives stemming from the wealth of innovation taking place at the university especially in medical imaging. While the focus is in the department of Neurology and the area of medical imaging, I am happy to work with and support anyone in UCL who would like business planning and support in looking at how to take their research into commercial application.” – Bruce Lynn